𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anthropometric measurements in non-small-cell lung cancer

✍ Scribed by Domenico Ferrigno; Gianfranco Buccheri


Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
111 KB
Volume
9
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


HMGA2 overexpression in non-small cell l
✍ Britta Meyer; Siegfried Loeschke; Anke Schultze; Thomas Weigel; Martin Sandkamp; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 318 KB πŸ‘ 1 views

## Abstract Lung cancer is still the leading cause of death from cancer worldwide primarily because of the fact that most lung cancers are diagnosed at advanced stages. Overexpression of the high mobility group protein HMGA2 has been observed in a variety of malignant tumors and often correlates wi

Contemporary brachytherapy approaches in
✍ Hilaris, Basil S.; Mastoras, Dina A. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

Brachytherapy has the ability to deliver a higher tumor dose compared to external beam irradiation, while sparing normal tissue outside the tumor; it is the most effective means of delivering conformal radiation and can be tailored to clinical circumstances, either at open surgery or in an ambulator

Thorax perfusion CT in non-small cell lu
✍ Gulgun Yilmaz Ovali; Aysin Sakar; Cihan GΓΆktan; PΔ±nar Γ‡elik; Arzu YorgancΔ±oğlu; πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 397 KB

Objectives: We aimed to determine the perfusion differences according to the histological type, stage, volume and prognoses in the non-small cell carcinoma by thorax perfusion CT. Materials and methods: Twenty-four non-small cell carcinoma patients were included in the study. Thorax perfusion CT was

Simultaneous chemoradiation in advanced
✍ Julianna Pisch; Stephen Malamud; James Harvey; Edward J. Beattie πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 558 KB

We designed our study to evaluate the safety and efficacy of simultaneous chemoradiation therapy in an accelerated, twice-a-day schedule to improve local control and survival in advanced lung cancer patients. Forty-one patients were entered into the study. Twenty-three had stage IIIB and 18 had stag

Non-Small Cell Lung Cancer in Stages I–I
✍ Karl Wurstbauer; Hannes Weise; Heinz Deutschmann; Peter Kopp; Florian Merz; Mich πŸ“‚ Article πŸ“… 2010 πŸ› Springer 🌐 German βš– 285 KB